ELMHURST BLOODSTOCK LIMITED

Company Registration Number:
02097703 (England and Wales)

Unaudited statutory accounts for the year ended 30 September 2024

Period of accounts

Start date: 1 October 2023

End date: 30 September 2024

ELMHURST BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Directors report
Balance sheet
Additional notes
Balance sheet notes

ELMHURST BLOODSTOCK LIMITED

Directors' report period ended 30 September 2024

The directors present their report with the financial statements of the company for the period ended 30 September 2024

Principal activities of the company

The Company is principally engaged in bloodstock insurance.



Directors

The directors shown below have held office during the whole of the period from
1 October 2023 to 30 September 2024

J Needham
CM Needham


Secretary CM Needham

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
5 June 2025

And signed on behalf of the board by:
Name: CM Needham
Status: Secretary

ELMHURST BLOODSTOCK LIMITED

Balance sheet

As at 30 September 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 635 794
Total fixed assets: 635 794
Current assets
Debtors: 4 15,686 21,657
Cash at bank and in hand: 1,441 0
Total current assets: 17,127 21,657
Creditors: amounts falling due within one year: 5 ( 6,460 ) ( 11,452 )
Net current assets (liabilities): 10,667 10,205
Total assets less current liabilities: 11,302 10,999
Provision for liabilities: ( 115 ) ( 144 )
Total net assets (liabilities): 11,187 10,855
Capital and reserves
Called up share capital: 10,000 10,000
Profit and loss account: 1,187 855
Total Shareholders' funds: 11,187 10,855

The notes form part of these financial statements

ELMHURST BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 5 June 2025
and signed on behalf of the board by:

Name: J Needham
Status: Director

The notes form part of these financial statements

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover represents the value of commissions earned in the year and is recognised at the point of sale or by reference to the stage of completion of the service at the balance sheet date

    Tangible fixed assets depreciation policy

    Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses. Depreciation is calculated to write off the cost of tangible fixed assets over their estimated useful lives to the business. The annual depreciation rates and methods are as follows: Office Equipment -20% reducing instalments method

    Other accounting policies

    Taxation: Taxation represents the sum of tax currently payable and deferred tax. Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Debtors and Creditors Receivable/Payable Within One Year: Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 2 2

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 October 2023 10,223 10,223
Additions
Disposals
Revaluations
Transfers
At 30 September 2024 10,223 10,223
Depreciation
At 1 October 2023 9,429 9,429
Charge for year 159 159
On disposals
Other adjustments
At 30 September 2024 9,588 9,588
Net book value
At 30 September 2024 635 635
At 30 September 2023 794 794

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

4. Debtors

2024 2023
£ £
Trade debtors 15,686 11,054
Other debtors 0 10,603
Total 15,686 21,657
Debtors due after more than one year: 0 0

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

5. Creditors: amounts falling due within one year note

2024 2023
£ £
Bank loans and overdrafts 0 4,847
Taxation and social security 5,372 4,781
Accruals and deferred income 1,088 1,824
Total 6,460 11,452

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

6. Loans to directors

Name of director receiving advance or credit: J Needham
Description of the transaction:
Short Term Loan repaid in full by 31 May 2024
£
Balance at 30 September 2023 5,000
Advances or credits made:
Advances or credits repaid: 5,000
Balance at 30 September 2024 0

Name of director receiving advance or credit: CM Needham
Description of the transaction:
Short Term Loan repaid in full by 31 May 2024
£
Balance at 30 September 2023 5,000
Advances or credits made:
Advances or credits repaid: 5,000
Balance at 30 September 2024 0